» Articles » PMID: 34310495

Effectiveness of Hematoma Aspiration and Platelet-rich Plasma Muscle Injections for the Treatment of Hamstring Strains in Athletes

Overview
Specialty Orthopedics
Date 2021 Jul 26
PMID 34310495
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The effect of platelet-rich plasma (PRP) treatment on recovery in acute hamstring injuries is controversial. Previous study results are inconsistent, and a standardized therapeutic approach has not been established yet.

Purpose: To assess the treatment effect using a combination of hematoma aspiration and muscle strain PRP injection in partial hamstring muscle tears (grade 2 strains) in athletes.

Methods: Magnetic resonance imaging of athletes with grade 2 hamstring strains were reviewed from 2013 to 2018. From 2013 to 2015, athletes were treated conservatively, and from 2016 to 2018, with a combination of ultrasound-guided hematoma aspiration and PRP muscle strain injection. The outcome, including return-to-play (in days) and recurrence rate, was compared retrospectively between both groups (conservative vs aspiration/PRP) using ANOVA and Fisher's exact test. There was no significant difference in age, type of sport, and muscle involvement (including injury grade/location, hamstring muscle type, and length/cross-sectional area of the strain).

Results: Fifty-five athletes (28 treated conservatively, 27 with hematoma aspiration/PRP injection) were included. Average return-to-play time (mean) was 32.4 d in the conservative group and 23.5 d in the aspiration/PRP group (P < 0.001). Recurrence rate of the hamstring strain was 28.6% (8/28) in the conservative treatment group and less than 4% (1/27) in the aspiration/PRP group (P = 0.025).

Conclusions: Athletes with grade 2 hamstring strains treated with a combination of hematoma aspiration and PRP injection had a significantly shorter return-to-play and a lower recurrence rate compared with athletes receiving conservative treatment.

Citing Articles

Basic research for ultrasound-guided injection into skeletal muscle lesions in an experimental animal model.

Fujimoto K, Kanamoto T, Otani S, Miyazaki R, Ebina K, Nakata K Bone Joint Res. 2025; 14(1):33-41.

PMID: 39819782 PMC: 11739951. DOI: 10.1302/2046-3758.141.BJR-2024-0090.R1.


Skeletal muscle injury treatment using the Silk Elastin® injection in a rat model.

Nakata K, Ishikawa M, Kamei N, Miyaki S, Adachi N, Inoue K Regen Ther. 2024; 26:180-187.

PMID: 38948131 PMC: 11214263. DOI: 10.1016/j.reth.2024.05.012.


The Role of Platelet-Rich Plasma Injection for Muscle Strains in Athletes.

Vale D, Pereira A, Andrade J, Castro J Cureus. 2024; 16(5):e60585.

PMID: 38894806 PMC: 11184543. DOI: 10.7759/cureus.60585.


Current Status and Advancements in Platelet-Rich Plasma Therapy.

Pretorius J, Habash M, Ghobrial B, Alnajjar R, Ellanti P Cureus. 2023; 15(10):e47176.

PMID: 38021947 PMC: 10652151. DOI: 10.7759/cureus.47176.


Lower Extremity Muscle Injuries in the Overhead Athlete.

Koscso J, McElheny K, Carr 2nd J, Hippensteel K Curr Rev Musculoskelet Med. 2022; 15(6):500-512.

PMID: 35913667 PMC: 9789236. DOI: 10.1007/s12178-022-09786-z.